The drug, which is already sold as a tablet, is used for the treatment of pulmonary arterial hypertension in adults, an affliction that affects roughly 100,000 worldwide.
Share of Pfizer rose 14 cents to $18.25 after the news.
About EQUITIES:
Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.
Sign up for a free one-year subscription to EQUITIES Magazine
